Learning Objectives:

1. At conclusion of this activity, participants will be able to Describe the accelerated process for clinical trials regarding COVID-19 vaccines.

2. At conclusion of this activity, participants will be able to Understand the different technologies that are being tested in COVID-19 vaccines.

3. At conclusion of this activity, participants will be able to Appreciate the current controversies regarding distribution of the eventual new vaccine and when a pediatric trial should commence

Session date: 
Monday, October 12, 2020 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Stephen Schrantz